In liver cancer, mutations or dysregulation of key components of the Wnt pathway, such as β-catenin, adenomatous polyposis coli (APC), and Axin, results in the constitutive activation of Wnt signaling, thereby promoting tumor progression [5]. The gene discussed is APC; the disease is neoplasm.